Comprehensive Assessment of the Transition to Efanesoctocog Alfa Prophylaxis in a Paediatric Haemophilia A Cohort

Documenti analoghi

• Successful Treatment of Heavy Menstrual Bleeding in a Woman With Mild Haemophilia A Using Efanesoctocog Alfa
  di: Michael Iarossi, et al.
  Pubblicazione: (2026)
• Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND‐1 and XTEND‐Kids Studies
  di: Robert Klamroth, et al.
  Pubblicazione: (2025)
• The First Three Japanese Haemophilia A Patients in Whom Factor VIII Inhibitors Were Observed During Prophylactic Treatment With Efanesoctocog Alfa
  di: Tazuko Tokugawa, et al.
  Pubblicazione: (2025)
• Is Incubation for 30 Minutes at 56°C Sufficient to Fully Inactivate Efanesoctocog Alfa?
  di: Annette Bowyer
  Pubblicazione: (2025)
• Efanesoctocog Alfa Measurement on Stago Platforms: Can PTT‐Automate Close the Gap?
  di: Laura Banov, et al.
  Pubblicazione: (2026)